Why PPD Decentralized Clinical Trials
Are You Ready to Digitally Enable Your Trial?
Now, more than ever, it’s critical to have a strategy to implement remote engagement at scale to maintain and advance lifesaving clinical research. In this complimentary webinar, our experts will equip you with the essential building blocks needed to ensure your program continues forward in an era where digital avenues will be paramount.
“We are very pleased to be identified as a leader in DCT in ISG’s Provider Lens™ survey. Our teams have worked diligently over the last few years to establish best practices and advance lifesaving research using innovative digital modalities.”
“PPD is a dominant player in the decentralized trial space. ISG’s Provider Lens™ survey is proof of that designation. We bring unrivaled design and operational expertise to the table – increasing access for patients, creating efficiencies and enhancing data quality.”
“Our teams remove the complexities that customers face when needing to identify key partners and platforms. As a platform agnostic group, PPD brings the right partner based on customer need, including looking at the availability and fit for purpose needs of medical vs. sensor grade devices.”
“We are changing the way we do clinical research to reduce patient burden. Decentralization is at the core of our innovative strategies, resulting in immense benefit for patients, sites and customers. From our expertise to our agnostic approach, we are continuing to bring more innovation to PPD.”
Decentralized Clinical Trial Resources
Check out PPD® Digital’s extensive library of materials on decentralized clinical trials (DCTs)